Taysha Gene Therapies, Inc. - TSHA

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Jul 10, 2026 President and Head of R&D S D 200,000.0 6.24 1,248,000.0 936,410.0 View
Jun 02, 2026 A A 42,671.0 0.0 0.0 42,671.0 View
Jun 02, 2026 A A 21,335.0 0.0 0.0 1,176,559.0 View
Jun 02, 2026 A A 42,671.0 0.0 0.0 42,671.0 View
Jun 02, 2026 A A 21,335.0 0.0 0.0 241,289.0 View
Jun 02, 2026 A A 42,671.0 0.0 0.0 42,671.0 View
Jun 02, 2026 A A 21,335.0 0.0 0.0 127,178.0 View
Jun 02, 2026 A A 42,671.0 0.0 0.0 42,671.0 View
Jun 02, 2026 A A 21,335.0 0.0 0.0 127,178.0 View
Apr 13, 2026 President and Head of R&D M D 19,021.0 0.0 0.0 455,920.0 View
Apr 13, 2026 President and Head of R&D S D 200,000.0 4.46 892,000.0 1,136,410.0 View
Apr 13, 2026 President and Head of R&D M A 19,021.0 1.71 32,525.91 1,336,410.0 View
Feb 06, 2026 CHIEF FINANCIAL OFFICER S D 1,655.0 4.52 7,480.6 1,442,131.0 View
Jan 27, 2026 President and Head of R&D S D 26,918.0 4.61 124,091.98 1,317,389.0 View
Jan 27, 2026 President and Head of R&D S D 89,132.0 4.75 423,377.0 1,344,307.0 View
Jan 27, 2026 Chief Executive Officer S D 41,312.0 4.61 190,448.32 2,908,257.0 View
Jan 27, 2026 Chief Executive Officer S D 136,789.0 4.75 649,747.75 2,949,569.0 View
Jan 27, 2026 CHIEF FINANCIAL OFFICER S D 23,849.0 4.61 109,943.89 1,443,786.0 View
Jan 27, 2026 CHIEF FINANCIAL OFFICER S D 78,968.0 4.75 375,098.0 1,467,635.0 View